What is the correct technique for administering the hepatitis B vaccine?

How to Inject Hepatitis B Vaccine

Administer the hepatitis B vaccine by intramuscular injection into the deltoid muscle in adults and the anterolateral thigh in infants and neonates—never inject intravenously, intradermally, or into the gluteal region. 1

Injection Site Selection

Adults

• Deltoid muscle is the standard site for all adults 1
• The gluteal region must be avoided as it results in suboptimal immune response 1
• Research confirms deltoid injection produces the highest seroconversion rates and antibody titers compared to other sites 2

Infants and Neonates

• Anterolateral thigh is preferred in neonates and infants with smaller deltoid muscles 1
• The ventrogluteal site is an acceptable alternative, showing comparable immunogenicity (97.8% vs 97.6% protective titers) with potentially fewer local reactions 3, 4
• Both sites achieve similar geometric mean titers (427.5 mIU/mL for ventrogluteal vs 572.0 mIU/mL for anterolateral thigh) 3

Children and Adolescents

• Toddlers and children up to 10 years: deltoid region is appropriate 1
• Children over 10 years and adolescents: deltoid muscle 1

Needle Selection

The physician should determine final needle size based on patient age and target muscle size 1:

• Infants <12 months: 1-inch, 23-gauge needle for anterolateral thigh 1
• Toddlers and children ≤10 years: 5/8-inch, 25-gauge needle for deltoid 1
• Older children and adults: 1-inch, 23-gauge needle 1

Preparation and Administration Technique

1. Shake the vial well before withdrawal and use 1
2. Inspect visually for particulate matter, discoloration, and cracks—discard if present 1
3. The vaccine should appear as a slightly turbid white suspension after thorough agitation 1
4. Use the vaccine as supplied—no dilution necessary 1
5. Administer the full recommended dose 1
6. Discard any remaining vaccine in single-dose vials 1

Critical Pitfalls to Avoid

Route-Related Errors

• Never inject intradermally or intravenously 1
• Intradermal injection produces significantly lower seroconversion (78.1% vs 97.2% for intramuscular) and geometric mean titers (126 vs 1649 IU/L) 5
• Subcutaneous injection results in poor response (only 63% seroconversion) and increased local reactions including nodule formation 6

Site-Related Errors

• Avoid gluteal injection at all costs—this is the most common error leading to vaccine failure 1
• Gluteal injection deposits vaccine into fat rather than muscle, resulting in suboptimal immune response 1

Special Populations

Patients at Risk of Hemorrhage

• Subcutaneous administration may be used in hemophiliacs or those at bleeding risk 1
• Important caveat: This route produces lower geometric mean titers and increased incidence of subcutaneous nodules 1
• Use only when intramuscular injection poses hemorrhage risk 1

Hemodialysis Patients

• Require higher doses (40 mcg/2.0 mL) given as two 20 mcg injections 1
• May use one or two injection sites 1
• Follow 0,1,2,6-month schedule 1

Dosing by Age Group

• Infants (birth-10 years): 10 mcg/0.5 mL 1
• Adolescents (11-19 years): 10 mcg/0.5 mL (or 20 mcg/1.0 mL for alternate schedules) 1
• Adults (>19 years): 20 mcg/1.0 mL 1
• Adult hemodialysis: 40 mcg/2.0 mL 1

The standard schedule is 0,1, and 6 months for most populations 7, 1. Minimum intervals must be respected: at least 4 weeks between doses 1 and 2, at least 8 weeks between doses 2 and 3, and at least 16 weeks between doses 1 and 3 7.